Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 318Colonic Neoplasms 90Rectal Neoplasms 82Neoplasm Metastasis 42Pancreatic Neoplasms 40Carcinoma, Non-Small-Cell Lung 35Esophageal Neoplasms 25Neoplasms 21Stomach Neoplasms 20Esophageal Squamous Cell Carcinoma 14Adenocarcinoma Of Esophagus 12Squamous Cell Carcinoma of Head and Neck 11Lung Neoplasms 11Head and Neck Neoplasms 11Colorectal Cancer Metastatic 11Breast Neoplasms 9Gastrointestinal Neoplasms 7Ovarian Neoplasms 6Anus Neoplasms 6Hereditary Sensory and Autonomic Neuropathies 5Endometrial Neoplasms 5Cholangiocarcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Salivary Gland Neoplasms 4Recurrence 4Digestive System Neoplasms 4Advanced Colorectal Cancer 4Tongue Neoplasms 3

Interventions

zolbetuximab 1trifluridine tipiracil drug combination 1tipiracil 1camrelizumab 1Trifluridine 1Taxes 1Oxaliplatin 1HMPL-013 1Docetaxel 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Cancer Adenocarcinoma Metastatic × Cetuximab × Gastrointestinal × Clear all
NCT00517829 2016-11-28

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

US Oncology Research

Phase 2 Completed
150 enrolled 12 charts
Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡